Interferon Beta-1a Treatment Promotes COVID-19 Vaccine Response in MS Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple Sclerosis and Related Disorders
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Interferon Beta-1a treatment promotes SARS-CoV-2 mRNA vaccine response in multiple sclerosis subjects
Mult Scler Relat Disord 2022 Feb 01;58(xx)103455, GT Maniscalco, V Manzo, AL Ferrara, A Perrella, M Di Battista, S Salvatore, D Graziano, A Viola, G Amato, O Moreggia, D Di Giulio Cesare, S Barbato, G Servillo, K Longo, M Di Giovanni, B Scarpati, SM Muggianu, G Longo, G Russo, V Andreone, V De RosaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.